

Mersana Therapeutics develops a biodegradable polymer platform Fleximer(R) which creates new and better medicines. Among its major competitors, Mersana Therapeutics is ranked in 2nd place for NPS while Biogen is 1st, and Reata Pharmaceuticals is 3rd.Their current market cap is $979.14M
Mersana Therapeutics's Net Promoter Score (NPS) is a -100 with 0% Promoters, 0% Passives, and 100% Detractors. Net Promoter Score tracks whether Mersana Therapeutics's customers would recommend using the product based on a scale of -100 to 100.
| 0% | Promoters |
|---|---|
| 0% | Passives |
| 100% | Detractors |
| Summary | Date | Score |
|---|---|---|
Mar 2023 -100 | Mar 2023 | -100 |
Mersana Therapeutics is ranked second for NPS among its competitors. Biogen and Reata Pharmaceuticals come in first and third, with Akumentis Healthcare coming in at #4. Among those competitors, it is the third most valued company behind Biogen.
![]() Mersana Therapeutics | ![]() Biogen | ![]() Reata Pharmaceuticals | ![]() Akumentis Healthcare | |
| Global Ranking | #- | #388 | #- | #- |
| NPS | -100 | 21 | - | - |
| Social Sentiment Calculated by analyzing social media and other online mentions | - | Neutral | - | - |
| Valuation Updated every 24 hours for public companies | $979.14M | $42.46B | $2.95B | - |
Net Promoter Score (NPS) is a management tool that can be used to gauge the satisfaction of a firm's customer relationships. NPS has been widely adopted as a key metric often linked to the revenue potential of a company’s product or service. The metric is based on customer responses to the question: "On a scale of 0 to 10, how likely are you to recommend the product to a friend?"
Those who respond with a score of 9 to 10 are known as Promoters, and are widely associated with behaviors that create value, including actively encouraging others to use the product or service. Those who respond with a score of 7 or 8 are categorized as Passives, and they are believed to be less likely to exhibit the value-creation traits of Promoters having a largely neutral effect on other consumers. Detractors are those who fall in the score range of 0 to 6 and represent dissatisfied customers of the product sometimes actively recommending against using the product.
Compared to its competitors, Mersana Therapeutics's NPS is rated right below Shire.
| COMPANY | NPS Score | |
|---|---|---|
![]() | Biogen | 21 |
![]() | Reata Pharmaceuticals | N/A |
![]() | Akumentis Healthcare | N/A |
![]() | Shire | N/A |
![]() | Mersana Therapeutics | -100 |
Mersana Therapeutics has an overall Product Quality score of 4 out of 5 stars rated by its users and customers.
Sign Up to unlock Mersana Therapeutics' overall Product Quality score rated by its users and customers.
Mersana Therapeutics’s product quality score is a 4 out of 5 as rated by its users and customers.
Compared to its competitors, Mersana Therapeutics's Product Quality score is rated right above Reata Pharmaceuticals, and is preceded by Biogen.
| COMPANY | Product Quality Score | |
|---|---|---|
![]() | Biogen | 4/5 |
![]() | Mersana Therapeutics | 4/5 |
![]() | Reata Pharmaceuticals | N/A |
![]() | Akumentis Healthcare | N/A |
![]() | Shire | N/A |
Customer Satisfaction Score (also known as CSAT), is a metric used to quantify how satisfied customers are with a company or brand’s products and services. The Customer Satisfaction Score is based on customers response to the question: “How would you rate your overall satisfaction with the service you received?” The score is calculated using the formula: (The total number answer of “Very Satisfied” and “Satisfied”) ÷ (The total response) x100, and it is generally displayed in percentages. Some of the main benefits of the CSAT for businesses are tracking retention, identifying happy customers and growing relationships, and gaining repeat business to build a sustainable brand.
Compared to its competitors, Mersana Therapeutics's Customer Satisfaction score is rated right above Reata Pharmaceuticals, and is preceded by Biogen.
| COMPANY | Customer Satisfaction (CSAT) Score | |
|---|---|---|
![]() | Biogen | 78% |
![]() | Mersana Therapeutics | 0% |
![]() | Reata Pharmaceuticals | 0% |
![]() | Akumentis Healthcare | 0% |
![]() | Shire | 0% |
Mersana Therapeutics has a 4.2/5 stars for its overall company culture rated by their employees

Mersana Therapeutics scored a -100 for Net Promoter Score and a 67 for Employee Net Promoter Score. NPS gauges how likely a customer of Mersana Therapeutics would recommend the brand to a friend. ENPS measures how likely Mersana Therapeutics employees would recommend working at Mersana Therapeutics to a friend.
| 0% | Promoters |
|---|---|
| 0% | Passive |
| 100% | Detractors |
| 67% | Promoters |
|---|---|
| 33% | Passive |
| 0% | Detractors |